CENB.F Stock Overview
CEN Biotech, Inc. focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
CEN Biotech, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0031 |
52 Week High | US$0.15 |
52 Week Low | US$0.0013 |
Beta | 0 |
1 Month Change | -48.33% |
3 Month Change | -69.00% |
1 Year Change | -82.78% |
3 Year Change | -99.75% |
5 Year Change | n/a |
Change since IPO | -99.84% |
Recent News & Updates
Recent updates
Shareholder Returns
CENB.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | -38.0% | 0.9% | 1.2% |
1Y | -82.8% | 13.9% | 24.7% |
Return vs Industry: CENB.F underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: CENB.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
CENB.F volatility | |
---|---|
CENB.F Average Weekly Movement | 231.0% |
Pharmaceuticals Industry Average Movement | 9.9% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CENB.F's share price has been volatile over the past 3 months.
Volatility Over Time: CENB.F's weekly volatility has increased from 196% to 231% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | n/a | Brian Payne | www.cenbiotechinc.com |
CEN Biotech, Inc. focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products. It intends to cultivate hemp for usage in industrial, medical, and food products; and to provide digital marketing and web design related services. The company was incorporated in 2013 and is based in Windsor, Canada.
CEN Biotech, Inc. Fundamentals Summary
CENB.F fundamental statistics | |
---|---|
Market cap | US$202.29k |
Earnings (TTM) | -US$3.10m |
Revenue (TTM) | US$1.03m |
0.0x
P/S Ratio0.0x
P/E RatioIs CENB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CENB.F income statement (TTM) | |
---|---|
Revenue | US$1.03m |
Cost of Revenue | US$0 |
Gross Profit | US$1.03m |
Other Expenses | US$4.13m |
Earnings | -US$3.10m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did CENB.F perform over the long term?
See historical performance and comparison